Jaundice due to erythromycin estolate.
A 43-year-old male developed abdominal pain and jaundice after the administration of erythromycin estolate. The diagnosis was strongly suspected on clinical grounds, but ultimate confirmation depends upon the demonstration of biochemical and morphological alterations after challenge with the drug.
D000005:Abdomen; D000208:Acute Disease; D000328:Adult; D001652:Bile Ducts / Q000648:ultrastructure; D001707:Biopsy, Needle; D004721:Endoplasmic Reticulum / Q000648:ultrastructure; D004917:Erythromycin / Q000031:analogs & derivatives*; D004918:Erythromycin Estolate / Q000009:adverse effects* / Q000627:therapeutic use; D006003:Glycogen; D006801:Humans; D007565:Jaundice / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology; D008099:Liver / Q000473:pathology / Q000648:ultrastructure; D008111:Liver Function Tests; D008297:Male; D008854:Microscopy, Electron; D008856:Microscopy, Fluorescence; D010146:Pain / Q000139:chemically induced; D010612:Pharyngitis / Q000188:drug therapy; D012008:Recurrence
D004917:Erythromycin; D006003:Glycogen; D004918:Erythromycin Estolate